18466256

Source:http://linkedlifedata.com/resource/pubmed/id/18466256

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:18466256	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0087111	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0019944	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0004238	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C1274040	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0332189	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0013778	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C1521761	lld:lifeskim
pubmed-article:18466256	lifeskim:mentions	umls-concept:C0205210	lld:lifeskim
pubmed-article:18466256	pubmed:issue	3	lld:pubmed
pubmed-article:18466256	pubmed:dateCreated	2008-5-16	lld:pubmed
pubmed-article:18466256	pubmed:abstractText	Transvenous electrical cardioversion (TVEC) has been developed for treatment of atrial fibrillation (AF) in horses. The relationship among patient variables, treatment response, and outcome in a typical referral population has not been evaluated.	lld:pubmed
pubmed-article:18466256	pubmed:language	eng	lld:pubmed
pubmed-article:18466256	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:18466256	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:18466256	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:18466256	pubmed:issn	0891-6640	lld:pubmed
pubmed-article:18466256	pubmed:author	pubmed-author:Physick-Shear...	lld:pubmed
pubmed-article:18466256	pubmed:author	pubmed-author:KenneyD GDG	lld:pubmed
pubmed-article:18466256	pubmed:author	pubmed-author:McGurrinM K...	lld:pubmed
pubmed-article:18466256	pubmed:issnType	Print	lld:pubmed
pubmed-article:18466256	pubmed:volume	22	lld:pubmed
pubmed-article:18466256	pubmed:owner	NLM	lld:pubmed
pubmed-article:18466256	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:18466256	pubmed:pagination	609-15	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:meshHeading	pubmed-meshheading:18466256...	lld:pubmed
pubmed-article:18466256	pubmed:articleTitle	Transvenous electrical cardioversion of equine atrial fibrillation: patient factors and clinical results in 72 treatment episodes.	lld:pubmed
pubmed-article:18466256	pubmed:affiliation	Department of Clinical Studies, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada. mcgurrin@uoguelph.ca	lld:pubmed
pubmed-article:18466256	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:18466256	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:18466256	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed